AzTrials
AzTrials

Low Back Pain, RecurrentHELBPNCT04074798

Hyperventilation in Patients With Chronic Low Back Pain

A study of Low Back Pain, Recurrent and Hyperventilation Syndrome, run by Hasselt University at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Low back pain (LBP) is the leading cause of disability worldwide. Impaired postural control is a key factor in the development and maintenance of LBP. Moreover, the prevalence of LBP is associated with impairments in diaphragm function, symptoms of dyspnea, and dysfunctional breathing. Read more about this study

Who is it for?
Ages 20 to 60 yearsHealthy volunteers can take part
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
90 participants
Where
1 siteBelgium
Study dates
1 Mar 2020to 1 Sep 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Chronic primary low back pain (>12 weeks) as diagnosed by a medical doctor
  • No low back pain

Who cannot join

  • Insufficient understanding of Dutch language
  • Previous spinal surgery
  • Chronic Obstructive Lung Disease, Interstitial Lung Disease, pulmonary vascular disease, asthma except for exertional asthma
  • Acute cardiovascular or gastrointestinal disorders
  • Neuromuscular disease interfering with normal lower limb or trunk functioning
  • Acute pain or secondary chronic pain
Show all 10Show fewer
  • Pregnant and lactating women
  • Major psychiatric conditions
  • Acute lower limb problems
  • Vestibular disorders

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Hasselt University

    Hasselt, 3590

Other trials in Belgium

About this study

Low back pain (LBP) is the leading cause of disability worldwide. Impaired postural control is a key factor in the development and maintenance of LBP. Moreover, the prevalence of LBP is associated with impairments in diaphragm function, symptoms of dyspnea, and dysfunctional breathing. However, the association between LBP (and more specifically postural control) and hyperventilation remains unknown. The main objective of this project is to investigate whether the presence of recurrent non-specific LBP is related to the presence of hyperventilation, when classified either objectively by decreased carbon dioxide values (demonstrating hypocapnia) or by symptoms while showing normal carbon dioxide values. Moreover, the investigators will explore whether psychosocial factors play a role in this relation. Subsequently, the investigators will examine whether hyperventilation in LBP patients is related to impaired postural control, and more specifically to a decreased postural contribution of the diaphragm.

Being tested
assessment of hyperventilation, postural control and psychological behavior
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • assessment of hyperventilation, postural control and psychological behaviorBehavioural

    assessment of hyperventilation, postural control and psychological behavior

Study groups in NCT04074798
Study groupRoleWhat they receive
Patients with low back painActive comparatorNot described
Receives: Behavioral: assessment of hyperventilation, postural control and psychological behavior
Healthy controlsSham comparatorNot described
Receives: Behavioral: assessment of hyperventilation, postural control and psychological behavior

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nijmegen questionnaire

    Questionnaire evaluating hyperventilation symptoms, 16 items, total score range 0-64

    Measured: Day 1

  2. Nijmegen questionnaire

    Questionnaire evaluating hyperventilation symptoms, 16 items, total score range 0-64

    Measured: Day 4

  3. PetCO2

    End-tidal carbon dioxide pressure measured with a capnograph

    Measured: Day 1

  4. Postural control

    upright standing balance measured by center of pressure by force plate

    Measured: Day 1

Secondary outcomes (17)
  1. Breathing frequency

    amount of breaths per minute, inspiratory and expiratory time

    Measured: Day 1

  2. Breathing pattern (abominal and thoracic)

    abdominal or thoracic contribution to one breath measured by respiratory inductance plethysmography

    Measured: Day 1

  3. Numerical Rating Scale for low back pain (NRS)

    11 point Likert scale evaluating severity/intensity of back pain, ranging from 0 (no pain) to 11 (worst pain imaginable)

    Measured: Day 1

  4. Oswestry Disability Index version 2.1a (ODI-2.1a)

    Questionnaire evaluating disability. 10 items Total score range from 0-100

    Measured: Day 1

  5. 12-item Short form Health Survey (SF-12)

    Questionnaire evaluating physical and mental components of health related quality of life. 12 items. Total score range 12-56.

    Measured: Day 1

  6. Fear Avoidance Component Scale (FACS)

    Questionnaire evaluating fear-avoidance related to pain. 20 items Total score range from 0-100

    Measured: Day 1

  7. Tampa Scale for Kinesiophobia (TSK)

    Questionnaire evaluating kinesiophobia related to pain. 17 items. Total score range from 17-68

    Measured: Day 1

  8. Pain Catastrophizing Scale (PCS)

    Questionnaire evaluating catastrophizing. 13 items, 5 point Likert scale. Total score 0-52

    Measured: Day 1

  9. Need for Controllability and Predictability Questionnaire (NCP-Q)

    Questionnaire evaluating the need for being able to control and predict situations. 15 items, 5 point Likert scale. Total score range 15 - 75

    Measured: Day 1

  10. Positive And Negative Affect Schedule (PANAS)

    Questionnaire evaluating positive and negative affect. 10 items positive affect, 10 items negative affect, 5 point Likert scale. Total score range per affect: 10 - 50

    Measured: Day 1

  11. Pain Solutions Questionnaire (PaSoL)

    Questionnaire evaluating assimilative and accommodative responses to problems associated with pain. 14 items, 7 point Likert scale. Total score range 0 - 84

    Measured: Day 1

  12. Toronto Alexithymia Scale 20 (TAS-20)

    Questionnaire evaluating characteristics linked to alexithymia. 20 items, 3 factors. Total score range 20 - 100

    Measured: Day 1

  13. Interoceptive Awareness Questionnaire (IAQ)

    Questionnaire evaluating adaptive and maladaptive body awareness. 19 items, 5 point Likert scale.

    Measured: Day 1

  14. Fremantle Back Awareness Questionnaire (FreBAQ)

    Questionnaire evaluating back specific perceptual awareness. 9 items, 5 point Likert scale. Total score range 0-36

    Measured: Day 1

  15. Vragenlijst belastende ervaringen (VBE) - short version

    Questionnaire evaluating aversive experiences in adult life. 11 items should be scored with yes or no. If yes a score on a 5 point Likert scale should be given.

    Measured: Day 1

  16. Multidimensional Perfectionism Scale (MPS)

    Questionnaire evaluating adaptive and maladaptive perfectionism. 35 items, 5 point Likert scale. Total score range 35 - 175

    Measured: Day 1

  17. International Physical Activity Questionnaire - Short Form (IPAQ-SF)

    Questionnaire evaluating subjective level of physical activity. 7 questions regarding amount of time spent on certain activities.

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Aug 2019
  2. Study start1 Mar 2020
  3. Primary completion1 Sep 2026
  4. Study completion1 Sep 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients with low back pain are compared to patients without low back pain (healthy controls).
Masking
Single blind
Who is masked
Participant
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04074798
Sponsor's protocol ID
CME ZOL - CTU2019078
Acronym
HELBP
Status last verified
Sep 2026
First submitted
28 Aug 2019
Last updated
17 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study of Low Back Pain, Recurrent and Hyperventilation Syndrome, run by Hasselt University at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nijmegen questionnaire (time frame: Day 1). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
HELBP Clinical Trial NCT04074798 | AzTrials